Intensification of infliximab therapy in Crohn's disease: Efficacy and safety-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Intensification of infliximab therapy in Crohn's disease: Efficacy and safety

Published:2012-02 Issue:1 Volume:6 Page:62-67
ISSN:1873-9946
Container-title:Journal of Crohn's and Colitis
language:en
Short-container-title:Journal of Crohn's and Colitis

Author:

M.Chaparro ,Martínez-Montiel P.,Van Domselaar M.,Bermejo F.,Pérez-Calle J.L.,Casis B.,Román A. López-San,Algaba A.,Maté J.,Gisbert J.P.

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Link

http://academic.oup.com/ecco-jcc/article-pdf/6/1/62/7094170/6-1-62.pdf

Reference21 articles.

1. Crohn's disease: a review of current treatment with a focus on biologics;Panes;Drugs,2007

2. Review article: infliximab therapy for inflammatory bowel disease — seven years on;Rutgeerts;Aliment. Pharmacol. Ther.,2006

3. American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21–23, 2006;Clark;Gastroenterology,2007

4. American Gastroenterological Association Institute medical position statement on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease;Lichtenstein;Gastroenterology,2006

5. Infliximab dose intensification in Crohn's disease;Regueiro;Inflamm. Bowel Dis.,2007

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Study of the Effectiveness of Vedolizumab Versus Ustekinumab After Anti-TNF Failure in Crohn’s Disease (Versus-CD): Data from the ENEIDA Registry;Journal of Crohn's and Colitis;2023-07-31

2. Dose Escalation Patterns of Advanced Therapies in Crohn’s Disease and Ulcerative Colitis: A Systematic Literature Review;Advances in Therapy;2023-03-17

3. Point-of-care therapeutic drug monitoring of tumour necrosis factor-α inhibitors using a single step immunoassay;Sensors & Diagnostics;2023

4. Systematic review and meta-analysis: evaluating response to empiric anti-TNF dose intensification for secondary loss of response in Crohn’s disease;Therapeutic Advances in Gastroenterology;2022-01

5. Systematic review: efficacy of escalated maintenance anti‐tumour necrosis factor therapy in Crohn's disease;Alimentary Pharmacology & Therapeutics;2021-06-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3